1. Home
  2. BBNX vs CANG Comparison

BBNX vs CANG Comparison

Compare BBNX & CANG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BBNX
  • CANG
  • Stock Information
  • Founded
  • BBNX 2015
  • CANG 2010
  • Country
  • BBNX United States
  • CANG Hong Kong
  • Employees
  • BBNX N/A
  • CANG N/A
  • Industry
  • BBNX Medical/Dental Instruments
  • CANG Computer Software: Prepackaged Software
  • Sector
  • BBNX Health Care
  • CANG Technology
  • Exchange
  • BBNX Nasdaq
  • CANG Nasdaq
  • Market Cap
  • BBNX 967.6M
  • CANG 811.9M
  • IPO Year
  • BBNX 2025
  • CANG 2018
  • Fundamental
  • Price
  • BBNX $22.26
  • CANG $4.74
  • Analyst Decision
  • BBNX Strong Buy
  • CANG Strong Buy
  • Analyst Count
  • BBNX 10
  • CANG 1
  • Target Price
  • BBNX $26.10
  • CANG $8.00
  • AVG Volume (30 Days)
  • BBNX 1.2M
  • CANG 598.6K
  • Earning Date
  • BBNX 11-06-2025
  • CANG 11-03-2025
  • Dividend Yield
  • BBNX N/A
  • CANG N/A
  • EPS Growth
  • BBNX N/A
  • CANG N/A
  • EPS
  • BBNX N/A
  • CANG N/A
  • Revenue
  • BBNX $78,022,000.00
  • CANG $398,195,540.00
  • Revenue This Year
  • BBNX $42.80
  • CANG $514.68
  • Revenue Next Year
  • BBNX $34.58
  • CANG $18.40
  • P/E Ratio
  • BBNX N/A
  • CANG N/A
  • Revenue Growth
  • BBNX 550.45
  • CANG 380.74
  • 52 Week Low
  • BBNX $8.89
  • CANG $1.55
  • 52 Week High
  • BBNX $26.66
  • CANG $9.66
  • Technical
  • Relative Strength Index (RSI)
  • BBNX 56.75
  • CANG 54.52
  • Support Level
  • BBNX $19.07
  • CANG $4.12
  • Resistance Level
  • BBNX $21.08
  • CANG $4.35
  • Average True Range (ATR)
  • BBNX 1.44
  • CANG 0.22
  • MACD
  • BBNX -0.45
  • CANG 0.03
  • Stochastic Oscillator
  • BBNX 52.15
  • CANG 88.04

About BBNX Beta Bionics Inc. Common Stock

Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.

About CANG Cango Inc. each representing two (2)

Cango Inc through its subsidiaries, variable interest entities (VIEs), and subsidiaries of the VIEs, are principally engaged in the bitcoin mining business, and the automobile trading transaction, automotive financing facilitation, and aftermarket service facilitation businesses (collectively, the automobile and related businesses). The Company conducts the bitcoin mining business mainly through its subsidiaries, and the automobile and associated businesses are conducted through the Company's VIEs and the subsidiaries of the VIEs. The company derives the majority of its revenue from the bitcoin mining business.

Share on Social Networks: